Cargando…

Regulation of ERBB3/HER3 signaling in cancer

ERBB3/HER3 is emerging as a molecular target for various cancers. HER3 is overexpressed and activated in a number of cancer types under the conditions of acquired resistance to other HER family therapeutic interventions such as tyrosine kinase inhibitors and antibody therapies. Regulation of the HER...

Descripción completa

Detalles Bibliográficos
Autores principales: Mujoo, Kalpana, Choi, Byung-Kwon, Huang, Zhao, Zhang, Ningyan, An, Zhiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279368/
https://www.ncbi.nlm.nih.gov/pubmed/25400118